MPWT
VRCA icon

MassMutual Private Wealth & Trust’s Verrica Pharmaceuticals VRCA Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7
Closed -$1K – 1648
2021
Q4 		$1K Buy
+7
New +$793 ﹤0.01% 1327

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

MassMutual Private Wealth & Trust's VRCA Position: Q1 2022 in Review

MassMutual Private Wealth & Trust sold out of Verrica Pharmaceuticals (VRCA) in Q1 2022, closing a stake of 7 shares — an estimated $1K sold.

MassMutual Private Wealth & Trust first reported a position in VRCA in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 51 funds tracked by Wall St. Rank hold VRCA as of Q1 2022.

  • MassMutual Private Wealth & Trust reported no remaining Verrica Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 7 Verrica Pharmaceuticals shares in Q1 2022, an estimated $1K.
  • MassMutual Private Wealth & Trust first reported a position in Verrica Pharmaceuticals in Q4 2021 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Verrica Pharmaceuticals position peaked at $1K in Q4 2021.
  • 51 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2022, filed 8 Apr 2022.